drugset / Trial / NCT00527579

PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB

NCT00527579 ↗

Phase 1 Completed 24 enrolled National Institute of Mental Health (NIMH)
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this protocol is to measure peripheral benzodiazepine receptors in the brain using positron emission tomography (PET) and compare the imaging results between patients and healthy people.

Timeline

Start
2007-09-04
Primary completion
2013-11-26
Completion
2013-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject [F-18]FBR Diagnostic / imaging agent — —

Indications